Lifeboat Foundation

Discover breaking news, innovative companies and an active community of investors all in one place.

GitHub Copilot dubs itself as an “AI pair programmer” for software developers, automatically suggesting code in real time. According to GitHub, Copilot is “powered by Codex, a generative pretrained AI model created by OpenAI” and has been trained on “natural language text and source code from publicly available sources, including code in public repositories on GitHub.”

However, a class-action lawsuit filed against GitHub Copilot, its parent company Microsoft, and OpenAI claims open-source software piracy and violations of open-source licenses. Specifically, the lawsuit states that code generated by Copilot does not include any attribution to the original author of the code, copyright notices, or a copy of the license, which most open-source licenses require.

“The spirit of open source is not just a space where people want to keep it open,” says Sal Kimmich, an open-source developer advocate at Sonatype, machine-learning engineer, and open-source contributor and maintainer. “We have developed processes in order to keep open source secure, and that requires traceability, observability, and verification. Copilot is obscuring the original provenance of those [code] snippets.”

We spoke to Sara Ord, director of species restoration at Colossal, the world’s first “de-extinction” company, about its big ambitions.

In May 2020, AI research laboratory OpenAI unveiled the largest neural network ever created—GPT-3—in a paper titled, ‘Language Models are Few Shot Learners’. The researchers released a beta API for users to toy with the system, giving birth to the new hype of generative AI.

People were generating eccentric results. The new language model could transform the description of a web page into the corresponding code. It emulates the human narrative, by either writing customised poetry or turning into a philosopher—predicting the true meaning of life. There’s nothing that the model can’t do. But there’s also a lot it can’t undo.

As GPT-3 isn’t that big of a deal for some, the name remains a bit ambiguous. The model could be a fraction of the futuristic bigger models that are yet to come.

J. Robert Oppenheimer speaks those famous words.

This video was posted on the 66th anniversary of the atomic bombing of Hiroshima.

Harvard University geneticist Dr. David Sinclair’s lab is developing a cheek swab test kit so that you can check your biological age at home. You then get updates on how to slow down and reverse your aging.

Find out how fast you’re aging with Tally Health. The future of healthy aging is here.

Washington, Scientists have found a novel immunotherapy that could bolster the effectiveness of cancer treatment, according to a study. Rather than rally T cells against cancer, scientists have used different human immune cells called natural killer (NK) cells as a novel means to fight cancer, according to a study.

The team of scientists at Albert Einstein College of Medicine described findings that could boost the impact of immune-checkpoint therapy, the study said. Findings have been published in The Journal of Clinical Investigation (JCI).

Immune checkpoint inhibitors such as Keytruda and Opdivo work by unleashing the immune system’s T cells to attack tumour cells. Their introduction a decade ago marked a major advance in cancer therapy, but only 10 per cent to 30 per cent of treated patients experience long-term improvement, the study said.

Triple threat. Tripledemic. A viral perfect storm. These frightening phrases have dominated recent headlines as some health officials, clinicians, and scientists forecast that SARS-CoV-2, influenza, and respiratory syncytial virus (RSV) could surge at the same time in Northern Hemisphere locales that have relaxed masking, social distancing, and other COVID-19 precautions.

But a growing body of epidemiological and laboratory evidence offers some reassurance: SARS-CoV-2 and other respiratory viruses often “interfere” with each other. Although waves of each virus may stress emergency rooms and intensive care units, the small clique of researchers who study these viral collisions say there is little chance the trio will peak together and collectively crash hospital systems the way COVID-19 did at the pandemic’s start.

“Flu and other respiratory viruses and SARS-CoV-2 just don’t get along very well together,” says virologist Richard Webby, an influenza researcher at St. Jude Children’s Research Hospital. “It’s unlikely that they will circulate widely at the same time.”

Metamorworks/iStock.

The study was conducted at the University of Limerick’s (UL) Bernal Institute in Ireland by a team of researchers from across the globe who created a new type of organic material that can learn from its prior behavior.